MAGED4 and glioma: To determine the cytotoxicity of MAGE-D4-specific T cells, the expression of immunomarkers in CD8+ T cells induced by MAGE-D4-specific DC was detected by flow cytometry and ELISA in epigenetic drug-treated glioma cells.